BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Baumgart DC. What’s new in inflammatory bowel disease in 2008? World J Gastroenterol 2008; 14(3): 329-330 [PMID: 18200655 DOI: 10.3748/wjg.14.329]
URL: https://www.wjgnet.com/2220-315x/full/v14/i3/329.htm
Number Citing Articles
1
Francesco Tonelli, Francesco Giudici, Gadiel Liscia. Is lymphatic status related to regression of inflammation in Crohn's disease?World Journal of Gastrointestinal Surgery 2012; 4(10): 228-233 doi: 10.4240/wjgs.v4.i10.228
2
David Benharush, Matan J Cohen, Yair Kasirer, Dan Turner. Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisCochrane Database of Systematic Reviews 2010;  doi: 10.1002/14651858.CD008730
3
Lin Deng, Jin-Feng Zhou, Rani S. Sellers, Jiu-Feng Li, Andrew V. Nguyen, Yubao Wang, Amos Orlofsky, Qiang Liu, David A. Hume, Jeffrey W. Pollard, Leonard Augenlicht, Elaine Y. Lin. A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated TumorigenesisThe American Journal of Pathology 2010; 176(2): 952 doi: 10.2353/ajpath.2010.090622
4
Rebekka Mueller, Farah Ziade, Valérie Pittet, Nicolas Fournier, Jessica Ezri, Alain Schoepfer, Susanne Schibli, Johannes Spalinger, Christian Braegger, Andreas Nydegger. Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?Journal of Crohn's and Colitis 2016; 10(3): 269 doi: 10.1093/ecco-jcc/jjv199
5
Anastassios C. Manolakis, Andreas N. Kapsoritakis, Anastasia Kapsoritaki, Elisavet K. Tiaka, Konstantinos A. Oikonomou, Vassilis Lotis, Dimitra Vamvakopoulou, Ioanna Davidi, Nikolaos Vamvakopoulos, Spyros P. Potamianos. Readressing the Role of Toll-Like Receptor-4 Alleles in Inflammatory Bowel Disease: Colitis, Smoking, and SeroreactivityDigestive Diseases and Sciences 2012;  doi: 10.1007/s10620-012-2348-4
6
Raj Kumar, Tamanna Islam, Md Nurunnabi. Mucoadhesive carriers for oral drug deliveryJournal of Controlled Release 2022; 351: 504 doi: 10.1016/j.jconrel.2022.09.024
7
Helga-Paula Török, Burkhard Göke, Astrid Konrad. Pharmacogenetics of Crohn’s diseasePharmacogenomics 2008; 9(7): 881 doi: 10.2217/14622416.9.7.881
8
Eric Lui. Systemic Causes of Heel PainClinics in Podiatric Medicine and Surgery 2010; 27(3): 431 doi: 10.1016/j.cpm.2010.04.004
9
Esra Küpeli Akkol, Büşra Karpuz, Eduardo Sobarzo-Sánchez, Haroon Khan. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitisFood and Chemical Toxicology 2020; 144: 111628 doi: 10.1016/j.fct.2020.111628
10
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel diseaseExpert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
11
L.H. Lian, T.P. Lau, V.L. Lee, W.S. Lee, I. Hilmi, K.L. Goh, K.H. Chua. Lack of association between TYK2 and STAT3 genes and Crohn’s disease in the Malaysian populationGenetics and Molecular Research 2013; 12(1): 167 doi: 10.4238/2013.January.24.9
12
Franca Viola, Fortunata Civitelli, Giovanni Di Nardo, Maria Beatrice Barbato, Osvaldo Borrelli, Salvatore Oliva, Francesca Conte, Salvatore Cucchiara. Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's DiseaseThe American Journal of Gastroenterology 2009; 104(10): 2566 doi: 10.1038/ajg.2009.372